Podcasts about chief medical officers

Join Our Medical Device Sales Program: https://click.newtomedicaldevicesales.com/yt-431If you're new to my channel, my name is Jacob McLaughlin. I'm the founder of New to Medical Device Sales, an exclusive training program designed to help people break into the competitive field of medical device sales. Our average person lands a six-figure role in just 9.5 weeks, earning $113,760 annually. With thousands of success stories from candidates with all kinds of backgrounds, our program equips you with the tools to succeed in this industry.4 years ago I moved out to Arizona not knowing anyone and had $1200 to my name.I came to this exact spot to journal and share how excited I was to be starting my journey in life.Last night I took time to reflect over the past 4 years. It's truly amazing how you can change your life in such a small amount of time.My take aways:1. Go after your dream because even if it doesn't workout like you thought it would, it will bring your right where you're suppose to be.2. Believe in yourself. Nobody is going to believe in you as much as you will, know that good things will happen.3. Change is inevitable. Change is going to happen so you can either accept it and keep moving forward or not.Please bet on yourself and go after your dreams because your life can be better than you ever thought it could be if you do

Behind every public health response are two make-or-break factors: the people doing the work and the systems that help them work together.  First, Shirley Orr, Executive Director of the Association of Public Health Nurses discusses the Public Health Nursing Workforce Learning Lab Series Session 5 with insights from PHWINS, the nation's only survey of the state and local public health workforce, which reached nearly 50,000 professionals. The data paints a detailed picture of who makes up today's workforce, including an influx of younger staff, persistent leadership diversity gaps, and ongoing concerns about burnout and morale. Later, Dr. Lisa Villarroel, Chief Medical Officer for Public Health of the Arizona Department of Health Services shows us what happens when that workforce is connected in real time. Arizona's Statewide Healthcare Collaborative Forum, a simple monthly virtual call during respiratory season, brings EMS, hospitals, post-acute care, and public health leaders together to review virus trends, hospital capacity, ED diversion, and emerging challenges. Born from pandemic lessons, the forum has led to tangible results: resolving EMS transport delays, sparking regional hospital alliances, rethinking masking policies, and aligning state data with frontline reality.Meeting Home PageMeeting Home Page

In this episode, Dr. Sidney H. Raymond, Chief Medical Officer at Ochsner Health Network, discusses leading population health across more than 600,000 lives and advancing value based care beyond contract boundaries. He shares how care model redesign, prevention focused strategies, digital health, and patient centered culture are driving measurable gains in quality, cost, and care coordination across diverse communities.

Superpowers for Good should not be considered investment advice. Seek counsel before making investment decisions. When you purchase an item, launch a campaign or create an investment account after clicking a link here, we may earn a fee. Engage to support our work.Watch the show on television by downloading the e360tv channel app to your Roku, LG or AmazonFireTV. You can also see it on YouTube.Devin: What is your superpower?Dr. Sahasranam: Emotional intelligence.Diabetes education saves lives, yet only 5 to 7 percent of people with diabetes ever receive it. This startling gap in care is the driving force behind My Diabetes Tutor, a telehealth platform founded by Dr. Prem Sahasranam. His mission? To make diabetes education accessible to everyone, regardless of geography or socioeconomic barriers.Dr. Sahasranam, a board-certified endocrinologist with nearly two decades of experience, explained how critical education is in diabetes management: “Studies have shown that just going through diabetes education reduces A1C by 0.73 points. At our program, our outcomes are two times better than the national average.” With over 9,000 patients served, My Diabetes Tutor consistently delivers remarkable results, achieving an average A1C reduction of 1.6 points—enough to significantly lower complications and mortality rates.The idea for My Diabetes Tutor was born out of necessity. Dr. Sahasranam shared a story about how two full-time diabetes educators in his rural California practice helped patients achieve exceptional outcomes. When they retired in 2018, he struggled to recruit replacements, a problem endemic to underserved areas. “I decided to build a telehealth program,” he said. “My goal was to solve an access issue and deliver diabetes education to people, irrespective of their zip code or language.”My Diabetes Tutor provides nationally accredited virtual diabetes education, covering medical nutrition therapy, continuous glucose monitoring, insulin pump training, and more. The platform recently launched the first-ever pediatric diabetes education program, a groundbreaking step toward addressing the needs of young patients.Dr. Sahasranam's vision extends beyond patient outcomes to include investor participation. My Diabetes Tutor is currently raising capital through a regulated crowdfunding campaign on StartEngine. “I want investors to own a piece of our growth and be part of our journey,” he said. The company generated over $2 million in revenue last year with a 61 percent gross margin, demonstrating both impact and financial viability.Dr. Sahasranam's work is not just about business; it's a mission to transform lives. By breaking down barriers to education, he's giving people the tools to manage their diabetes effectively, live healthier lives, and reduce complications.For those looking to make a difference—or simply to invest in a business delivering measurable impact—My Diabetes Tutor offers a unique opportunity.tl;dr:Dr. Prem Sahasranam founded My Diabetes Tutor to provide virtual education for diabetes management.The program addresses barriers to care in underserved communities by delivering telehealth services nationwide.My Diabetes Tutor achieves outcomes twice as effective as national averages in reducing A1C levels.The company generated over $2 million in 2025 and is raising capital via StartEngine crowdfunding.Prem credits emotional intelligence as his superpower, driving his mission to revolutionize diabetes care.How to Develop Emotional Intelligence As a SuperpowerDr. Prem describes his superpower as emotional intelligence, honed through years of experience as a board-certified endocrinologist. He explained, “Most health systems focus on the biology of the disease and fail to address the human part.” By understanding the emotional and practical needs of patients, Prem has created innovative solutions to improve access to diabetes education. He added, “I learned from my experience and built the right team, content, and technology to bring in diabetes education, easily accessible for patients.”Prem shared a pivotal story of a patient who had been struggling to control their diabetes despite receiving appropriate medications. The patient hesitated to make a two-hour drive to see Prem but eventually visited his practice and met with a diabetes educator. Without altering the patient's medications, the educator provided tailored guidance that helped the patient manage their condition. This experience inspired Prem to create My Diabetes Tutor, ensuring patients could access life-changing education from their own homes.Tips for Developing Emotional Intelligence:Reflect on past experiences to identify unmet needs and learn from them.Stay aware of the human challenges behind systemic issues.Focus on creating solutions that address both emotional and practical barriers.Build strong, empathetic teams that align with your mission.By following Dr. Prem's example and advice, you can make emotional intelligence a skill. With practice and effort, you could make it a superpower that enables you to do more good in the world.Remember, however, that research into success suggests that building on your own superpowers is more important than creating new ones or overcoming weaknesses. You do you!Get Your Copy!Guest ProfileDr. Prem Sahasranam (he/him):Founder, CEO, and Chief Medical Officer, My Diabetes Tutor (MDT)About My Diabetes Tutor (MDT): My Diabetes Tutor (MDT) is an ADCES-accredited telehealth service that provides comprehensive Diabetes Self-Management Education and Support (DSMES) via virtual, 1-on-1 sessions with Certified Diabetes Care and Education Specialists (CDCES). We bridge the gap for the 93% of eligible patients who currently do not utilize DSMES due to access barriers. We accept Medicare, Medicaid, and most private insurance (often with $0 out-of-pocket for patients). Participants achieve an average 1.6 pt reduction in A1C, 2x the national average for diabetes education.Website: mydiabetestutor.comCompany Facebook Page: facebook.com/mydiabetestutorInstagram Handle: @mydiabetestutor_Other URL: startengine.com/offering/my-diabetes-healthBiographical Information: Prem Sahasranam, MD (Dr. Sahas) is a Board-Certified Endocrinologist with over 20 years of clinical experience. He founded My Diabetes Tutor in 2019 to address the critical shortage of specialists in rural “care deserts”. A graduate of Madras Medical College with post-graduate training at Cornell University's Weill Medical College, he is currently an Assistant Clinical Professor at Loma Linda University and a dedicated advocate for health equity.LinkedIn Profile: linkedin.com/in/prem-sahasranam-ba10077Personal Facebook Profile: facebook.com/PremsahasranamThe Super Crowd, Inc., a public benefit corporation, is proud to have been named a finalist in the media category of the impact-focused, global Bold Awards.Support Our SponsorsOur generous sponsors make our work possible, serving impact investors, social entrepreneurs, community builders and diverse founders. Today's advertisers include rHealth, and Make Money with Impact Crowdfunding. Learn more about advertising with us here.Max-Impact Members(We're grateful for every one of these community champions who make this work possible.)Brian Christie, Brainsy | Cameron Neil, Lend For Good | Carol Fineagan, Independent Consultant | Hiten Sonpal, RISE Robotics | John Berlet, CORE Tax Deeds, LLC. | Justin Starbird, The Aebli Group | Lory Moore, Lory Moore Law | Mark Grimes, Networked Enterprise Development | Matthew Mead, Hempitecture | Michael Pratt, Qnetic | Mike Green, Envirosult | Nick Degnan, Unlimit Ventures | Dr. Nicole Paulk, Siren Biotechnology | Paul Lovejoy, Stakeholder Enterprise | Pearl Wright, Global Changemaker | Scott Thorpe, Philanthropist | Sharon Samjitsingh, Health Care Originals | Add Your Name HereUpcoming SuperCrowd Event CalendarIf a location is not noted, the events below are virtual.SuperCrowd Impact Member Networking Session: Impact (and, of course, Max-Impact) Members of the SuperCrowd are invited to a private networking session on February 17th at 1:30 PM ET/10:30 AM PT. Mark your calendar. We'll send private emails to Impact Members with registration details. Upgrade to Impact Membership today!SuperCrowdHour February: This month, Devin Thorpe will be digging deep into my core finance expertise to share guidance on projections and financial statements. We're calling it “Show Me the Numbers: Building Trust with Financial Clarity.” Register free to get all the details. February 18th at Noon ET/9:00 PT.Superpowers for Good Live Pitch: The top-raising Reg CF campaign of 2025 won the June 2025 Superpowers for Good Live Pitch. We're taking applications for the March 17, 2026, Live Pitch now. There is no fee to apply and no fee to pitch if selected! Apply here now!Community Event CalendarSuccessful Funding with Karl Dakin, Tuesdays at 10:00 AM ET - Click on Events.If you would like to submit an event for us to share with the 10,000+ changemakers, investors and entrepreneurs who are members of the SuperCrowd, click here.Manage the volume of emails you receive from us by clicking here.We use AI to help us write compelling recaps of each episode. Get full access to Superpowers for Good at www.superpowers4good.com/subscribe

In this episode of the progesterone series, Dr. Brendan McCarthy — Chief Medical Officer of Protea Medical Center in Tempe, Arizona — explores the often misunderstood relationship between progesterone, estrogen, and breast health. For decades, women have been taught to fear their breasts and fear hormones. While awareness matters, fear is disempowering — and it has left many women confused about what's actually happening in their bodies. In this episode, we discuss: Why breast tissue is dynamic, not static How estrogen stimulates growth and progesterone restores balance The role of progesterone in breast tissue maturation and architecture Why dense or fibrocystic breasts often reflect unopposed estrogen How restoring ovulation and progesterone can reduce breast pain and density in some women The difference between natural progesterone vs synthetic progestins Where the fear around progesterone and breast cancer really came from Progesterone is not something to fear — it is a hormone of organization, balance, and maturation. Understanding how it works allows women to approach breast health with clarity instead of anxiety.

Medicare for all. Not socialized medicine, just a single, government-run system that provides healthcare.  Is it possible? Or even viable? Our guest this week on the Creating a New Healthcare podcast believes so. In fact, he sees it as the only way to ultimately address the affordability problem with healthcare, particularly for high cost conditions like cancer. In today's episode, we talk with Dr. Troy Brennan about his book, The Transformation of American Health Insurance: On the Path to Medicare for All, and why a single payer, government system is needed, and how the changes the current administration has made to our public health systems is taking us backwards, not forward. Troyen Brennan is an Adjunct Professor at Harvard Chan School of Public Health.  He was formerly the Executive Vice President and Chief Medical Officer for CVS Health and Aetna. Before that, he was the President of the Brigham and Women's Physician Organization and Professor of Medicine at Harvard Medical School.  He was also Professor of Law and Public Health at the Harvard Chan School of Public Health.  Brennan was formerly the Chair of the American Board of Internal Medicine and is a member of the National Academy of Medicine. He has published six books and over 600 articles. 

(February 11, 2026) Nancy Guthrie: Video released, person detained and released. Los Angeles and Long Beach among the least affordable cities in the world. Dr. Jim Keany, Chief Medical Officer at Dignity Health St. Mary Medical Center in Long Beach, joins The Bill Handel Show for 'Medical News'! Dr. Keany joins the show from Milan, Italy and the Winter Olympics where his AirBnB had… BED BUGS!See omnystudio.com/listener for privacy information.

In this episode, Dr. Andy Cutler talks with Dr. Tim Wilens about enduring myths surrounding ADHD diagnosis and treatment, beginning with why misconceptions about overdiagnosis and misuse continue to shape clinical hesitation. They explore common misunderstandings about ADHD medications—including stimulants versus non-stimulants, concerns about diversion, personality changes, and long-term safety—and contrast stigma-driven narratives with the clinical evidence. The conversation equips clinicians with practical, evidence-based strategies to address patient fears, counter misinformation, and make thoughtful, individualized treatment decisions.  Timothy Wilens, MD, is chief of the Division of Child and Adolescent Psychiatry and is co-director of the Center for Addiction Medicine at Massachusetts General Hospital. He is the MGH Trustees Chair in Addiction Medicine and a professor of psychiatry at Harvard Medical School. Dr. Wilens' research interests include the relationship among attention deficit/hyperactivity disorder (ADHD), bipolar disorder, and substance use disorders, embedded health care models, and the pharmacotherapy of ADHD across the lifespan.   Andrew J. Cutler, MD, is a distinguished psychiatrist and researcher with extensive experience in clinical trials and psychopharmacology. He currently serves as the Chief Medical Officer of Neuroscience Education Institute and EMA Wellness. He is a Clinical Associate Professor of Psychiatry at SUNY Upstate Medical University in Syracuse, New York.  Save $100 on registration for 2026 NEI Spring Congress with code NEIPOD26  Register today at nei.global/spring  Never miss an episode!

Is Artificial Intelligence actually helping cancer patients, or is it just noise? In this episode of The Patient From Hell, Samira sits down with Dr. Shadi Nabhan to separate the Hype from the Reality in 2026.We discuss the massive evolution in oncology—from the "library days" of 1995 to the AI-driven diagnostics of today. Dr. Shadi shares his "Airport Analogy" for navigating a cancer diagnosis, offers a life-changing reframe on how we view advanced disease (it's not just "curable" vs. "terminal"—it can be "controllable"), and gives his #1 piece of advice for selecting a medical team that will actually show up for you when things get hard.Key Topics Discussed:AI in 2026: How doctors use AI to simplify complex terms like CAR T-cell therapy and why patients need to "trust but verify" AI-generated medical advice.The "Controllable" Reframe: Why treating metastatic cancer like diabetes or hypertension changes the patient experience.Navigating the "Airport": Why the healthcare system feels like being dropped in a foreign airport without a map.Advice for the Industry: What Healthcare Systems and Pharma companies need to change right now regarding clinical trials and drug pricing.About Today's Guest Dr. Chadi Nabhan:Dr. Chadi Nabhan is a board-certified hematologist, oncologist, and the Chief Medical Officer at Ryght, Inc., where he leads the integration of Generative AI into clinical research to accelerate the delivery of lifesaving therapies. With a career spanning leadership roles at Caris Life Sciences and the University of Chicago, Dr. Nabhan is a prolific researcher with over 300 publications and a prominent author whose work focuses on the intersection of medicine, justice, and technology.AI Visionary: Leading the charge in using AI to optimize clinical trials and patient outcomes.Expert Clinician: Trained at Northwestern and Harvard, with decades of experience in malignant hematology.Renowned Author: Published three books with Johns Hopkins University Press, including The Cancer Journey and the forthcoming AI and Cancer Care (2026).Podcast Host: Voice of the popular weekly series Healthcare Unfiltered.Quotes from the Episode:"We cure more patients than we have ever dreamt of... Women who are affected by breast cancer today are more likely to be completely cured." "Availability is key. Are they going to really pick up the phone and talk to you when you need them?"00:00 - The reality of the cancer journey (It's not smooth sailing)01:00 - Intro: Dr. Shadi Nabhan & The Fun Factor01:25 - AI in Healthcare: Hype, Hope, and Reality04:15 - How doctors use AI to explain complex therapies06:38 - Warning for patients using AI: "Garbage in, Garbage out"08:45 - The Evolution of Medicine: 1995 vs. 202613:00 - The "Airport Analogy": Why patients feel lost17:30 - MUST WATCH: Reframing "Terminal" cancer as "Controllable"21:30 - Advice for Healthcare Leaders: Agility & Patient Involvement23:50 - Advice for Pharma: Drug Pricing & Accelerating Innovation26:00 - The #1 criteria for picking your medical team28:18 - The importance of Second Opinions28:50 - What to expect in late 2026: AI in Cancer Care Book

Dr. Howard Federoff, Scientific Co-Founder, Chief Medical Officer, and Executive Vice President of Corporate Medicine and Science at Kenai Therapeutics, is developing a cell therapy for Parkinson's disease that involves transplanting IPSCs into the brain to replace lost dopamine neurons.  The goal is not to cure the underlying cause of the disease, but to restore motor function and reverse the disease's progression. Initial clinical focus was on patients with moderate to moderate-severe idiopathic Parkinson's, showing efficacy and safety, leading to expanding the study to include earlier-stage and familial forms of the disease. Howard explains, "Kenai was formed about three and a half years ago, and the intention is to develop a cellular product, which means that what is manufactured will be eligible in the right patient groups who have a diagnosis of Parkinson's to be placed into the brain. And consequent to its placement, the cells will then form new circuits, dopamine circuits that are lost owing to the disease diagnosis that will have occurred years earlier." "The induced pluripotent stem cell approach is one we favor for several reasons. The nature of what then becomes the IPSC, as we like to call it, starts with a normal human volunteer whose medical history is very detailed and does not contain any familial personal history of neurodegeneration. That cell then undergoes a process called reprogramming. And in our case, it's done with a slightly different approach than many others. And the reprogramming effectively creates a cell that is pluripotent, meaning it can become any cell of the body. That's when it is designated as an induced pluripotent stem cell."  #KenaiTherapeutics #ParkinsonsDisease #CellTherapy #StemCells #Neuroscience #MedicalInnovation #ClinicalTrials #RegenerativeMedicine #Biotechnology #BioTech #AdvancedBiologics #NeurologicalDisorders #Neurology #DrugDevelopment KenaiTx.com Listen to the podcast here  

Dr. Howard Federoff, Scientific Co-Founder, Chief Medical Officer, and Executive Vice President of Corporate Medicine and Science at Kenai Therapeutics, is developing a cell therapy for Parkinson's disease that involves transplanting IPSCs into the brain to replace lost dopamine neurons.  The goal is not to cure the underlying cause of the disease, but to restore motor function and reverse the disease's progression. Initial clinical focus was on patients with moderate to moderate-severe idiopathic Parkinson's, showing efficacy and safety, leading to expanding the study to include earlier-stage and familial forms of the disease. Howard explains, "Kenai was formed about three and a half years ago, and the intention is to develop a cellular product, which means that what is manufactured will be eligible in the right patient groups who have a diagnosis of Parkinson's to be placed into the brain. And consequent to its placement, the cells will then form new circuits, dopamine circuits that are lost owing to the disease diagnosis that will have occurred years earlier." "The induced pluripotent stem cell approach is one we favor for several reasons. The nature of what then becomes the IPSC, as we like to call it, starts with a normal human volunteer whose medical history is very detailed and does not contain any familial personal history of neurodegeneration. That cell then undergoes a process called reprogramming. And in our case, it's done with a slightly different approach than many others. And the reprogramming effectively creates a cell that is pluripotent, meaning it can become any cell of the body. That's when it is designated as an induced pluripotent stem cell."  #KenaiTherapeutics #ParkinsonsDisease #CellTherapy #StemCells #Neuroscience #MedicalInnovation #ClinicalTrials #RegenerativeMedicine #Biotechnology #BioTech #AdvancedBiologics #NeurologicalDisorders #Neurology #DrugDevelopment KenaiTx.com Download the transcript here  

In this episode, Dr. Sidney H. Raymond, Chief Medical Officer at Ochsner Health Network, discusses leading population health across more than 600,000 lives and advancing value based care beyond contract boundaries. He shares how care model redesign, prevention focused strategies, digital health, and patient centered culture are driving measurable gains in quality, cost, and care coordination across diverse communities.

Patient-centered design is not a nice-to-have in healthcare. It is the key to access, trust, and better outcomes. In this episode, Dr. Justin Coffey, Chief Medical Officer at WorkIt Health, discusses how designing treatment around lived experience can transform substance use care. He explains the philosophy of patients as designers, why immediate access matters in moments of readiness, and how whole-person care better reflects the realities of recovery. The conversation highlights how digital care can reduce stigma, improve engagement, and reach underserved populations, including rural patients and pregnant individuals. Dr. Coffey shares practical examples of how technology, team-based care, and thoughtful design remove barriers while maintaining human connection and explores the future role of AI in supporting care delivery and patient empowerment. Tune in and learn how patient-designed digital care can create more accessible, humane, and effective treatment. Resources: Connect with and follow Dr. Justin Coffey on LinkedIn. Follow Workit Health on LinkedIn and explore their website.

Dr. Jeffrey Kopin, Chief Medical Officer, Northwestern Medicine Catherine Gratz Griffin Lake Forest Hospital, joins John Williams to talk about pacemaker technology, and a new study about coffee intake and dementia risk.

Dr. Jeffrey Kopin, Chief Medical Officer, Northwestern Medicine Catherine Gratz Griffin Lake Forest Hospital, joins John Williams to talk about pacemaker technology, and a new study about coffee intake and dementia risk.

In this episode, Dr. Greg Jones sits down with Dr. Sharon Hausman-Cohen, Chief Medical Officer of IntelliXX DNA, to explore how medical genomics is transforming the way we understand heart disease, brain health, inflammation, and metabolism. Most people think genetics stops at traits like eye color or ancestry. Genomics goes much deeper—analyzing how thousands of genes interact to influence cardiovascular risk, cognitive function, clotting tendencies, nutrient metabolism, and chronic inflammation.Dr. Hausman-Cohen explains why many direct-to-consumer DNA tests fall short, how incomplete interpretation can mislead patients, and why clinician-guided genomic analysis allows for truly personalized care. The conversation also dives into inflammation, methylation, homocysteine, cholesterol myths, caffeine metabolism, mitochondrial health, and women's unique clotting risks.Whether you're trying to reduce your risk of heart disease, improve mental clarity, or understand how your biology responds to diet, supplements, and medications—this episode offers a science-based roadmap for precision health.

Dr. Jeffrey Kopin, Chief Medical Officer, Northwestern Medicine Catherine Gratz Griffin Lake Forest Hospital, joins John Williams to talk about pacemaker technology, and a new study about coffee intake and dementia risk.

This episode's Community Champion Sponsor is Ossur. To learn more about their ‘Responsible for Tomorrow' Sustainability Campaign, and how you can get involved: CLICK HEREEpisode Overview: Clinical trials are the gateway to getting life-saving therapies to patients, yet traditional research methods often create barriers that slow progress and limit participation.Our next guest, Dr. Pamela Tenaerts, is tackling this challenge as Chief Medical Officer of Medable.With more than two decades of clinical research experience, including leadership of the Clinical Trials Transformation Initiative, Pamela possesses a unique perspective bridging rigorous science and digital innovation.Driven by a passion to ensure that evidence-based best practices guide how we transform research, Pamela shares Medable's pioneering vision to decentralize clinical trials and meet patients where they are.Join us to discover how Medable's digital platform is accelerating trials across 70 countries, expanding patient access, and getting effective therapies to people faster. Let's go!Episode Highlights:Evidence First: Always research whether a solution actually works before implementing—assumptions can be wrong.One, One, and One: Medable's vision is to start a study in one day, enroll in one day, and complete in one year.Expanding Access: Decentralized trials help rare disease and rural patients participate without traveling to research sites.AI Integration: Medable uses AI to instantly generate patient questionnaires and automate trial workflows.Finding Trials: Patients need easier ways to discover clinical trials that exist for their conditions.About our Guest:Pamela Tenaerts, MD, is Medable's Chief Medical Officer, and aims to drive advancement of decentralized research methodologies with evidence-based best practices. She brings more than two decades of clinical research experience having previously served as Executive Director of the Clinical Trials Transformation Initiative (CTTI), Director of Clinical Programs at Coaxia, Director of the Clinical Research Center at Sarasota Memorial Hospital, and various other research positions. She can be reached at pamela.tenaerts@medable.com.Links Supporting This Episode: Medable Website: CLICK HEREDr. Pamela Tenaerts LinkedIn page: CLICK HEREMike Biselli LinkedIn page: CLICK HEREMike Biselli Twitter page: CLICK HEREVisit our website:

Are you doing "all the right things" for menopause but still feel like your body didn't get the memo? Have you ever wondered why some women suffer longer, harder, and with fewer answers during the menopause transition? Well, sometimes it's down to race and ethnicity.  We cover: Why menopause symptoms last dramatically longer for some women, and what the SWAN Study reveals about race, ethnicity, and biology The foundational "trifecta" every woman needs before hormones can truly work Why basic cholesterol labs often miss real cardiovascular risk in midlife women Which advanced heart tests are most useful, and which are overhyped Where breast cancer screening should really begin, and what to do about the fear of mammograms Dr. Jessica Shepherd is a board-certified gynecologist, menopause specialist, and nationally recognized women's health expert. She is the Chief Medical Officer for Hers and the founder of Sanctum Med + Wellness in Dallas, where she helps women optimize their health. She is the author of Generation M, a book about menopause and longevity. Dr. Shepherd has appeared on Good Morning America, The Today Show, CNN, and many other media outlets. She serves on advisory boards for Women's Health Magazine, Women'sHealth.org, and the Society for Women's Health Research.  Generation M book: https://amzn.to/3Zmsdp1 Contact Dr. Jessica Shepherd: Instagram: https://www.instagram.com/jessicashepherdmd Website: https://www.jessicashepherdmd.com/ Email: hello@jessicashepherdmd.com Modern Meno: https://www.instagram.com/modernmeno/ Sanctum Well: https://www.sanctumwell.com/ Give thanks to our sponsors: Try Vitali skincare. 20% off with code ZORA here - https://vitaliskincare.com Get Primeadine spermidine by Oxford Healthspan. 15% discount with code ZORA ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠here⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ - http://oxfordhealthspan.com/discount/ZORA Get Mitopure Urolithin A by Timeline. 20% discount with code ZORA at https://timeline.com/zora Try Suji to improve muscle 10% off with code ZORA at TrySuji.com - https://trysuji.com Try OneSkin skincare with code ZORA for 15% off https://oneskin.pxf.io/c/3974954/2885171/31050   Join the Hack My Age community on: YouTube: https://youtube.com/@hackmyage Facebook Page: ⁠⁠⁠⁠⁠@⁠Hack My Age⁠     Facebook Group: ⁠⁠⁠⁠⁠⁠@⁠Biohacking Menopause⁠⁠⁠⁠⁠⁠ ⁠   Biohacking Menopause Private Women's Only Support Group: https://hackmyage.com/biohacking-menopause-membership/ Instagram: ⁠⁠⁠⁠⁠@⁠HackMyAge⁠    Website: ⁠⁠⁠⁠⁠⁠HackMyAge.com⁠    For partnership inquiries: https://www.category3.ca/  Some episodes of Hack My Age are supported by partners whose products or services may be discussed during the show. The host may receive compensation or earn a minor commission if you purchase through affiliate links at no extra cost to you. All opinions shared are those of the host and guests, based on personal experience and research, and do not necessarily represent the views of any sponsor. Sponsorships do not imply medical endorsement or approval by any healthcare provider featured on this podcast.

Chief Medical Officer of Northwestern Medicine's Northwest region of hospitals Dr. Irfan Hafiz joins Bob Sirott to talk about a new study on Alzheimer’s, new information about statins, and news about a cholesterol-lowering pill. He also shares what happens if you stop taking weight loss drugs, why it’s important to start your day with a […]

Australian conservationist and television personality Robert Irwin broke the news that the 49ers and Rams will play in the NFL's first Australia game next season at the Melbourne Cricket Ground. Irwin joined "49ers Talk" host Matt Maiocco, with a python in tow, to discuss what NFL fans can expect from the first game down under. Local legends, Giants broadcaster Dave Flemming and 49ers Hall of Fame linebacker Patrick Willis, followed to offer their views on San Francisco's offensive line and linebacking corps, respectively. Willis also shared what motivated him to make it to the NFL, while Flemming offered insight into his first impression of Heisman Trophy winner and College National Champion Fernando Mendoza. Matt then checked in with the NFL's Chief Medical Officer, Dr. Allen Sills, to get to the bottom of the 49ers' injury concerns. Finally, 49ers Hall of Fame wide receiver Jerry Rice stopped by to share how he grew out of his shell in the NFL and discusses what type of wideout the Red and Gold need to acquire for next season.--(8:30) Robert Irwin reveals NFL's first Aussie stop with 49ers-Rams rivalry booked for Melbourne(18:00) Patrick Willis opens up on NFL motivation, Jim Harbaugh's impact, current 49ers linebacking corps(27:00) Giants broadcaster Dave Flemming on Heisman Trophy winner Fernando Mendoza(40:30) NFL Chief Medical Officer Dr. Allen Sills analyzes 49ers' injuries, electrical substation theories(53:30) 49ers legend Jerry Rice identifies type of wide receiver SF needs in 2026 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Have you ever wondered what it was like to be in the room when the first pelvic embolization was performed or how the TIPS procedure was pioneered? Dr. Ernie Ring, a legendary figure from UCSF and a true forefather of Interventional Radiology, joins host Dr. Peder Horner to recount the early days of the specialty. Dr. Ring shares fascinating stories from his training at Massachusetts General Hospital under Dr. Stanley Baum, where he witnessed the birth of transformative techniques using angiographic catheters to treat life-threatening bleeding. --- SYNPOSIS From improvising the use of autologous blood clot and thrombin to stop massive hemorrhages to his pivotal role in developing the TIPS procedure and specialized biliary catheters, Dr. Ring's career is loaded with innovation. The conversation explores the "cowboy" era of IR, the evolution of essential tools like the glide wire, and the critical importance of maintaining a "high-touch" clinical practice in the face of emerging technologies like AI. Dr. Ring also reflects on his later transition into hospital leadership as Chief Medical Officer, where he applied his problem-solving mindset to institutional quality and safety. --- TIMESTAMPS 00:00 - Introduction01:58 - Upbringing from Detroit to Mass Gen 06:55 - Early IR with an Embo Case13:50 - Trailblazing Cases in IR16:17 - Penn and Innovation20:00 - Polarizing Procedures24:13 - IR Device Innovation33:00 - Dotter's Separation from Diagnostics37:30 - Fear Finds Cowboys39:08 - AI and Robotics40:08 - Fun Hobbies

Last month, the Centers for Disease Control and Prevention reversed course on decades of institutional knowledge and changed its vaccine recommendations for children. The shift has puzzled medical experts, and it leaves the CDC at odds with a longtime partner: the American Academy of Pediatrics. Senior Producer Lou DiVizio sat down with the state's top doctor, Miranda Durham, to try and unravel the confusion and break down what this all means for families in New Mexico.Podcast Host: Lou DiVizioGuest: Dr. Miranda Durham, Chief Medical Officer, NM Health Department 

She's a hometown Tiger who's come full circle — from state champion swimmer at Hickman High School to Mizzou student-athlete to the first-ever Chief Medical Officer for Mizzou Athletics. On this episode of “Mizzou Storytellers,” Dave Matter and Loretta Jones sit down with Dr. Tiffany Bohon to talk about building a brand-new, embedded medical model for student-athletes, how her own experience in the pool shaped her approach to care and what holistic athlete health really looks like behind the scenes. Dr. Bohon also shares stories from working with the New York Giants, New York Mets and USA Swimming, reflects on leadership, trust, and return-to-play decisions, and offers a candid look at the moments fans never see during high-pressure seasons. From Columbia roots to SEC sidelines, this is a conversation about medicine, mentorship and what it means to serve the next generation of Tigers.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Unexplained infertility, PMS, and low progesterone are often dismissed when labs fall “within range.” In this episode, Dr. Brendan McCarthy explains why prolactin may be the missing piece. Learn how mildly elevated prolactin can suppress ovulation, lower progesterone, and impact fertility—even when labs appear normal. We also discuss common causes, symptoms, the role of stress and medications, and why diet (including gluten sensitivity) may matter. This episode focuses on precision medicine, not fear—helping you understand what standard reference ranges often miss. Citations: Research — Prolactin and Breast Cancer Risk Below are key epidemiologic and review papers that inform the discussion in this episode regarding prolactin and breast biology. These studies look at associations, not simple cause-and-effect relationships, and help explain why prolactin shows up in breast health conversations. Meta-analysis: circulating prolactin and breast cancer risk Wang M, et al. (2016). Plasma prolactin and breast cancer risk: a meta-analysis. Cancer Causes & Control. This meta-analysis pooled data from multiple observational studies comparing women with higher versus lower circulating prolactin levels. Across studies, higher prolactin levels were associated with a modest but statistically significant increase in breast cancer risk. The association was most evident in postmenopausal women and in hormone-receptor–positive tumors. This helps explain why prolactin is considered a relevant growth signal in breast tissue rather than just a “lactation hormone.” Systematic review and meta-analysis: prolactin levels across breast cancer cohorts Aranha AF, et al. (2022). Impact of prolactin levels in breast cancer: a systematic review and meta-analysis. Endocrine-Related Cancer. This more recent systematic review and meta-analysis evaluated circulating prolactin levels across breast cancer populations and control groups. Elevated prolactin levels were associated with higher breast cancer occurrence, with stronger associations seen in invasive cancers and hormone-receptor–positive disease. This paper adds weight to the idea that prolactin participates in breast biology in ways that matter clinically, even outside of pregnancy and breastfeeding. Prospective cohort studies: prolactin measured before diagnosis Tworoger SS, et al. (2004; 2006). Prospective analyses from large cohorts including the Nurses' Health Study. In these studies, prolactin was measured years before any breast cancer diagnosis. Women with higher prolactin levels had a higher likelihood of developing breast cancer later, particularly estrogen-receptor–positive tumors in postmenopausal women. Because prolactin was measured before cancer developed, these studies help clarify timing and reduce the concern that elevated prolactin is simply a consequence of disease. Mechanistic context (supportive background) Experimental and translational studies show that prolactin receptor signaling influences mammary epithelial cell growth, differentiation, and interaction with estrogen signaling pathways. This provides a biologic backdrop for why epidemiologic associations between prolactin and breast cancer risk keep appearing across different study designs. How to read this as a clinician or patient These data do not mean prolactin “causes” breast cancer in a simple or deterministic way. What they do show is that prolactin is an active hormone in breast tissue, and chronically higher levels are consistently associated with changes in breast risk profiles across large populations. That's why prolactin deserves attention in conversations about fertility, breast symptoms, and long-term hormonal signaling—not fear, and not dismissal.    Dr. Brendan McCarthy is the founder and Chief Medical Officer of Protea Medical Center in Arizona. With over two decades of experience, he's helped thousands of patients navigate hormonal imbalances using bioidentical HRT, nutrition, and root-cause medicine. He's also taught and mentored other physicians on integrative approaches to hormone therapy, weight loss, fertility, and more. If you're ready to take your health seriously, this podcast is a great place to start.  

4:20 pm: Josh Findlay, Director of the National Election Protection Project at the Texas Public Policy Foundation, joins the show for a conversation about in piece in Townhall about why America should use voter ID.4:38 pm: Senator Chris Wilson joins the program to discuss why the Utah Legislature is working so hard on judicial transparency during the current session and responds to criticism from the state's bar association.6:05 pm: Representative Paul Cutler joins Rod and Greg for a conversation about his proposed legislation to require people gathering signatures for a ballot initiative to undergo government training about what they must tell voters.6:38 pm: Dr. Kurt Miceli, Chief Medical Officer for Do No Harm, joins the show to discuss how the American Medical Association has now followed the American Society of Plastic Surgeons in condemning gender-affirming surgeries on children under 19 years of age.

When your child's life is shaped by medical complexity, childhood can quickly become defined by hospital stays, procedures, and limitations. In today's episode, we explore how medically supported camps transform that narrative—creating space for joy, belonging, and healing for children, families, and even healthcare providers themselves. Katie Taylor is joined by Dr. Laura Blaisdell, Chief Medical Officer of SeriousFun Children's Network, and Jamie Gentille, Child Life Specialist Leader and former camper, to share the life-changing impact of camp for children with serious illnesses. From zip-lining with oxygen tubing to late-night cabin chats that build confidence and identity, this conversation highlights how thoughtfully designed camp experiences allow kids to be kids—without compromising medical safety. This episode explores the power of positive childhood experiences, how camps seamlessly integrate complex medical care behind the scenes, the role of child life specialists and medical volunteers in creating safe spaces for play, and why camp is just as healing for providers as it is for children. You'll also hear Jamie's personal journey from camper to child life specialist and why camp will always feel like home. Explore Child Life On Call's directory of medical and disability-friendly summer camps for kids! This resource helps families find inclusive summer camp options that support children with medical needs and disabilities, making it easier to plan fun, safe, and engaging summer experiences. Today's Episode is sponsored by Moog Medical. Moog Medical is a trusted leader in infusion and enteral feeding technology, designing reliable, easy-to-use pumps that support safe, precise care for patients with complex medical needs—at home and in healthcare settings. Resources from today's episode: Medical & Camp Support: SeriousFun Children's Network Hole in the Wall Gang Camp Painted Turtle Camp Medical volunteer opportunities through SeriousFun  Connect & Support from Child Life On Call  Subscribe: Never miss an episode on Apple Podcasts or Spotify. Visit insidethechildrenshospital.com to search stories and episodes easily Follow us on Instagram for updates and opportunities to connect with other parents Download SupportSpot: receive Child Life tools at your fingertips. Leave a Review: It helps other families find us and access our resources! Keywords: Medically complex children, Pediatric medical camps, SeriousFun Children's Network, Child life specialist, Positive childhood experiences, Pediatric chronic illness support, Medical trauma healing, Camp for children with illness, Family-centered care, Pediatric resilience, Provider burnout prevention, Therapeutic play, Sibling support, Pediatric healthcare community Medical information provided is not a substitute for professional advice—please consult your care team  

(February 04, 2026) Hotels have anti-cat bias. Dr. Jim Keany, Chief Medical Officer at Dignity Health St. Mary Medical Center in Long Beach, joins The Bill Handel Show for 'Medical News'! Dr. Keany talks with Bill about new Measles cases, new studies regarding marijuana and pain, and Savanana Guthrie's mom's pacemaker last detection. See omnystudio.com/listener for privacy information.

In this episode, recorded live at the Becker's 13th Annual CEO + CFO Roundtable, Dave Newman discusses how Sanford Health is expanding access by innovating virtual care—meeting patients where they are, including by phone. He shares insight into preventive strategies for chronic kidney disease and emphasizes how collaboration across teams and technologies serves as a powerful catalyst for progress in modern care delivery.In collaboration with R1.

Dr. Jim Keany, Chief Medical Officer at Dignity Health St. Mary Medical Center in Long Beach, joins The Bill Handel Show for 'Medical News'! Dr. Keany talks with Bill about new Measles cases, new studies regarding marijuana and pain, and Savanana Guthrie's mom's pacemaker last detection. See omnystudio.com/listener for privacy information.

In this episode, Dr. Andy Anderson, Chief Medical Officer and Chief Quality Officer at RWJBarnabas Health, shares how the system is improving mortality outcomes and patient experience through rapid response teams, standardized best practices, and a strong culture of accountability. He discusses strategies for scaling success, coordinating care, and fostering growth across the health system.

What happens when a health system stops trying to recruit its way out of a workforce challenge, and instead redesigns the pipeline itself? In this episode of Bright Spots in Healthcare, Eric Glazer sits down with Dr. Lindsay Mazotti, Chief Medical Officer of Medical Science and Education at Sutter Health, for a candid, system-level conversation about rethinking how physicians are trained, supported, and developed for the future of care. Rather than focusing on workforce shortages as a policy or awareness problem, this conversation explores what happens after the reality is already clear—when leaders choose to redesign foundational systems instead of managing around constraints. Dr. Mazotti shares how Sutter is treating graduate medical education as strategic infrastructure, not an academic side function, and what it takes to build a physician pipeline that can scale, adapt, and endure. Using examples from rural training pathways, academic partnerships, research translation, and digital transformation, the discussion surfaces how education becomes the load-bearing structure that allows health systems to absorb change without breaking. This episode is designed for health system leaders who are no longer asking whether change is needed, but are grappling with how to build systems that can carry what's coming next. In this episode, we cover: Why physician shortages can't be solved through recruiting alone How Sutter is redesigning the physician pipeline end to end What changes when graduate medical education is treated as core infrastructure How training clinicians for place shapes rural and underserved care delivery Why education is the missing link between research, digital innovation, and day-to-day care Where clinician training determines adoption—or abandonment—of new technologies The leadership tradeoffs that come with moving from individual patient care to system-level impact What leaders must unlearn when building durable, long-term capability About Dr. Lindsay Mazotti: Dr. Lindsay Mazotti leads system-wide initiatives at Sutter Health that advance medical education, research, and innovation in support of the organization's mission to deliver exceptional, patient-centered care to more than 3 million patients across 22 counties in Northern California. In her role, she focuses on strategically integrating medical education into the health system's infrastructure to align with long-term priorities, including Sutter's Destination 2030 initiative. Dr. Mazotti oversees undergraduate and graduate medical education across the system—spanning clinical rotations, scholarships, residency and fellowship programs, and academic partnerships—while working closely with aligned medical groups representing more than 14,000 physicians to develop and support physician educators. Her work centers on building innovative training pathways that address physician workforce needs, align with evolving care delivery models, and strengthen long-term system capability, with the goal of quadrupling Sutter's GME footprint by 2030 to become the largest community-based GME program in California. Learn more about Dr. Mazotti - https://www.linkedin.com/in/lindsay-mazotti Partner with Bright Spots Ventures: If you are interested in speaking with the Bright Spots Ventures team to brainstorm how we can help you grow your business via content and relationships, email hkrish@brightspotsventures.com. About Bright Spots Ventures: Bright Spots Ventures is a healthcare strategy and engagement company that creates content, communities, and connections to accelerate innovation. We help healthcare leaders discover what's working, and how to scale it. By bringing together health plan, hospital, and solution leaders, we facilitate the exchange of ideas that lead to measurable impact. Through our podcast, executive councils, private events, and go-to-market strategy work, we surface and amplify the "bright spots" in healthcare—proven innovations others can learn from and replicate. At our core, we exist to create trusted relationships that make real progress possible. Visit our website at www.brightspotsinhealthcare.com. Visit our website:  www.brightspotsinhealthcare.com. Follow Bright Spots in Healthcare: https://www.linkedin.com/company/shared-purpose-connect

Dr. Jeffrey Kopin, Chief Medical Officer, Northwestern Medicine Catherine Gratz Griffin Lake Forest Hospital, joins John Williams to talk about the most common causes of knee and joint pain, new data suggesting that flu cases are rebounding, the rare medical condition that the great Catherine O’Hara discovered many years before her death, and if we need to […]

La medicina es una vocación que evoluciona junto con quienes la practican. Para muchos profesionales, el ejercicio clínico representa el corazón de su carrera, pero algunos deciden dar un paso fuera del consultorio, para influir en el sistema de salud desde una perspectiva más estratégica. Tal es el caso del pediatra que, tras años de dedicación al cuidado individual de los niños y sus familias, asumió el reto de convertirse en Chief Medical Officer (CMO), liderando equipos médicos, guiando políticas institucionales y mejorando la calidad del cuidado a nivel organizacional. Hablamos con el Dr. Matuk Villazón quien precisamente hizo esta transición y nos cuenta su testimonio de Pediatra a Chief Medical Officer o Director Médico. El Dr. Matuk tiene un título en medicina de la Universidad Nacional Autónoma de México (UNAM) y una especialización en Homeopatía y Medicina Integrativa en Homeopatía de México. Completó su residencia médica pediátrica en el Jackson Memorial Hospital y posee un MBA de la Universidad Rice. Es médico de atención primaria en práctica y actualmente imparte clases en la Escuela de Negocios de Posgrado Jones de la Universidad Rice, donde enseña gestión de la salud, modelos de riesgo total y emprendimiento. Por sus contribuciones a la estrategia de atención médica, liderazgo de médicos, investigación clínica y atención basada en el valor, ha sido reconocido por la Academia Americana de Pediatría y la Academia Nacional de Medicina de México. Actualmente el Dr. Matuk-Villazón es Chief Medical Officer (Director Médico) y Director de Servicios Clínicos de SuVida Healthcare, con centros de atención de salud en Texas y Arizona. Instagram: @‌dr.omarmatukvillazon ¿Tienes algún comentario sobre este episodio o sugerencias de temas para un futuro podcast?  Escríbenos a pediatrasenlinea@childrenscolorado.org.

Dr. Jeffrey Kopin, Chief Medical Officer, Northwestern Medicine Catherine Gratz Griffin Lake Forest Hospital, joins John Williams to talk about the most common causes of knee and joint pain, new data suggesting that flu cases are rebounding, the rare medical condition that the great Catherine O’Hara discovered many years before her death, and if we need to […]

Dr. Jeffrey Kopin, Chief Medical Officer, Northwestern Medicine Catherine Gratz Griffin Lake Forest Hospital, joins John Williams to talk about the most common causes of knee and joint pain, new data suggesting that flu cases are rebounding, the rare medical condition that the great Catherine O’Hara discovered many years before her death, and if we need to […]

This episode of Lung Cancer Considered, hosted by Dr. Narjust Florez, examines the challenges of delivering lung cancer care in areas affected by war and displacement with guests Dr. Julie Gralow and Dr. Rafal Dziadziuszko. The discussion addresses disrupted diagnosis and treatment, heightened inequities, and unique environmental exposures that may increase lung cancer risk in conflict settings. The episode also highlights emerging opportunities through global collaboration, adaptable care models, and shared responsibility across the oncology community. Guests: Dr. Julie Gralow, Chief Medical Officer and Executive Vice President of the American Society of Clinical Oncology (ASCO). She is also the founder of the Women's Empowerment Cancer Advocacy Network (WE CAN) and an expert in global oncology. Rafał Dziadziuszko, M.D., Ph.D., professor of medicine, Head, Department of Oncology & Radiotherapy and Early Phase Clinical Trials Centre, Medical University of Gdańsk in Poland

Distinguishing between ADHD and anxiety can feel a bit like trying to figure out if you're sneezing because of a cold or because your neighbor just started mowing their lawn - or maybe it's a bit of both, the symptoms look the same, but the solution is very different. This week, I'm talking with Dr. Mona Potter, a Harvard-trained, board-certified child and adolescent psychiatrist and the Chief Medical Officer and Co-founder of InStride Health. Dr. Potter spent years at McLean Hospital pioneering treatments for anxiety and OCD, and has a unique perspective on how we can manage the specific brand of exhaustion that comes with being neurodivergent in a world that never stops moving. Today, we're exploring the bio psycho social model—which is just a fancy way of saying we're looking at your sleep, your stress, and your chemistry all at once. We discuss the "optimal zone" of anxiety and how it can actually mask ADHD symptoms until you find a treatment that works, the difference between a "crutch" and a tool, and why parents (and adults) should stop trying to be the "external executive function" for everyone around them. We also take a deep dive into the specific mechanics of OCD and why the structure that saves an ADHDer might actually feed an obsessive loop. If you'd life to follow along on the show notes page you can find that at HackingYourADHD.com/269 YouTube: https://tinyurl.com/y835cnrk Patreon: https://www.patreon.com/HackingYourADHD This Episode's Top Tips To tell ADHD and anxiety apart, look at what's pulling your focus. ADHD distractions are often external (the world "tapping you on the shoulder"), while anxiety distractions are typically internal (a "side commentary" of what could go wrong). Remember that medication can turn down the biological "volume" of symptoms, but it doesn't build skills or "brain muscles." Use the quiet provided by medication as a window to practice the executive function habits you need. While structure and rituals are helpful for ADHD, they can feed OCD. If you have both, you must learn to sit with the distress of not performing a ritual (Exposure and Response Prevention) rather than making things "seamless".  

Dr. Will Haas, MD, MBA is redefining what it means to age well. He is the Founder and CEO of VYVE Wellness in Charlotte, NC, where he helps high-achieving professionals reclaim energy, focus, and vitality through cellular optimization. Board-certified in Integrative and Family Medicine, Dr. Haas blends advanced therapies—IV nutrient infusions, therapeutic peptides, hyperbaric oxygen, and red light therapy—to deliver measurable results that help patients feel decades younger. Beyond VYVE, he co-founded OvulifeMD, creating natural fertility protocols, and serves as Chief Medical Officer at Infusive, supporting wellness practices nationwide. His expertise has been featured in Men'sJournal, Daily Mail, Yahoo Life, and Woman's World Magazine. Passionate about bridging science with practical results, Dr. Haas empowers high-performers who want more than just longevity—they want their best years ahead of them. Dr. Will Haas Vroom Vroom Veer Summary Journey to Integrative Medicine William shared his journey from medical school to finding his passion in integrative medicine, which focuses on using a variety of healing modalities to optimize health. He initially struggled with the conventional approach to medicine, which primarily focuses on treating diseases, and decided to pursue business studies during his medical training. However, a personal loss led him to fulfill his father's dying wish to complete his medical degree. William eventually found his calling in integrative medicine, which he believes should be the standard approach to healthcare, combining the best of conventional and alternative treatments. Cellular Optimization and Health Strategies Jeffery and William discussed the concept of cellular optimization and the importance of addressing toxins and oxidative stress in the body. They explored how factors like poor diet, lack of sleep, and environmental exposure can contribute to cellular damage and reduced energy levels. Jeffery shared his personal experience of reducing sugar and processed foods intake, which led to improved health and well-being. They also touched on the idea of getting a CT scan for a calcium score as part of a proactive approach to prevent heart attacks. Cardiovascular Health Assessment Strategies Jeffery and William discussed cardiovascular health, diagnostic tests, and therapeutic peptides. William explained the importance of assessing inflammation levels, homocysteine, and other markers to evaluate heart attack risk. They talked about the benefits of advanced lipid panels and the role of Apo B and oxidized LDL in predicting cardiovascular events. William shared a success story of a patient who improved his health through dietary changes, gut healing, and IV nutrient therapies. They also briefly discussed the potential of therapeutic peptides under medical supervision. Connections Website

Chief Medical Officer at Central DuPage Hospital Dr. Tom Moran joins Bob Sirott to discuss how much red meat is too much and a study about men’s risk for heart attacks. He also talks about the link between staying up late and heart health as well as how genes play a significant role in your […]

Dr. Stonewall McCuiston, Riverside Vice President and Chief Medical Officer, joins us to discuss chronic health disparities and medical mistrust in the Black community, and what Riverside is doing to address these issues.  Learn more about Stonewall McCuiston, MD 

In this episode, Dr. Ria Paul, Clinical Associate Professor, Stanford University School of Medicine; Chief Medical Officer, Santa Clara Family Health Plan discusses how the organization has strengthened Medicaid and Medicare Advantage quality scores through closer collaboration with providers, targeted incentives, and better data flow. She also shares priorities for 2026, including regulatory readiness, member retention, and using AI to enhance engagement and care coordination.

In this episode, Andrew B. Wallach, Ambulatory Care Chief at NYC Health + Hospitals/Bellevue and Ambulatory Care Chief Medical Officer for NYC Health + Hospitals, joins the podcast to discuss how health systems can better support and sustain the workforce. He shares lessons learned from the pandemic, the role of internal float pools in managing patient surges, and strategies for building resilience and preparedness across ambulatory care teams.

In this episode, Dr. Jessica Shepard, board-certified OB/GYN and Chief Medical Officer of Hers, shares that the FDA just removed the black box warning on hormone replacement therapy after 23 years. We discuss what actually happened with the WHI study that created all the fear around estrogen and breast cancer, and why the research never actually supported that narrative.Dr. Shepard explains why you shouldn't wait until menopause to start the HRT conversation and how starting in your perimenopausal years can make all the difference for long-term health. Dr. Shepard shares the essential labs she runs on patients including ApoB, HbA1c, and thyroid optimization, plus the longevity metrics women should be tracking.We also get into supplement recommendations including why she recommends 10 grams of creatine daily, the role of inflammation in aging, and how estrogen is naturally anti-inflammatory which is why women see increased cardiovascular risk and metabolic dysfunction after menopause.Kayla's social + website:Instagram:  kaylabarnesTikTok:  femalelongevityTwitter: https://x.com/femalelongevityWebsite: https://www.kaylabarnes.comSpotify: https://open.spotify.com/show/4OLWWn2...Apple: https://podcasts.apple.com/us/podcast...Follow Her Female Protocol: https://www.protocol.kaylabarnes.comDr. Jessica Shepherd's social + website:Website: https://www.jessicashepherdmd.com/Instagram: https://www.instagram.com/jessicashepherdmd/Transform Your Health: https://eudemonia.net/?utm_source=podcast&utm_medium=kayla-podcast&utm_campaign=jessica-shepherd

In this episode of the Innovations and Clinical Implementation podcast recorded at LongevityFest 2025, host Dr. Lexi Gonzales discusses the future of scalable healthcare with Dr. Jeff Gladd—the Chief Medical Officer at Fullscript and a practicing integrative physician—and Ben Walters, the Head of Journeys at Fullscript. The conversation centers on Fullscript's evolution into a "Whole Person Care" engine designed to alleviate administrative burden by launching **Journeys**, a new platform that aggregates fragmented patient contexts like intake forms, historical labs, and wearables into "four clean walls" to facilitate true personalization. The guests explain how embedding AI directly into the clinical workflow allows practitioners to reduce the time spent on lab interpretation and plan creation from 45 minutes to under seven minutes, effectively allowing them to "5x" their patient capacity while utilizing tools like the PROM 10 framework to objectively validate clinical outcomes. For access to episode resources: https://sites.google.com/ovationlab.com/innovationsinclinicalimplement/home

(January 28, 2026) The hands of the ‘Doomsday Clock’ were set closer to midnight than ever before. California’s Highway 1 is fighting a losing battle against…. Weather. Dr. Jim Keany, Chief Medical Officer at Dignity Health St. Mary Medical Center in Long Beach, joins The Bill Handel Show for 'Medical News'! Dr. Keany talks with Bill about pediatricians urging Americans to stick to the vaccine schedule, the U.S. splitting with the World Health Organization, and marijuana not working as well for pain as once thought.See omnystudio.com/listener for privacy information.

As technology continues to redefine healthcare delivery, the role of the CMIO is expanding beyond data and systems, and into the heart of change management. From overseeing new rollouts and system upgrades to preparing clinicians for continual transformation, CMIOs and their teams are now tasked with orchestrating how organizations learn, adapt, and thrive in a digital-first environment. Increasingly, success depends not just on implementation, but on how well clinicians are supported before, during, and long after technology goes live.In this episode, Dr. Bryan Jarabek, Chief Medical Information Officer at M Health Fairview, joins Dr. Stephanie Lahr, Chief Medical Officer at uPerform, to explore how health systems can better navigate this era of rapid change. Together, they'll discuss how innovation, AI, and well-structured education programs are helping organizations move beyond reactive education to proactive, scalable change enablement. Hear how leading health systems are redefining their approach to health IT education – creating structured training teams, unifying education across mission-critical applications, and leveraging just-in-time learning to empower their people to keep pace with technology.As healthcare organizations look ahead to the next phase of digital transformation, this conversation will inspireIT leaders, CMIOs, and educators to rethink how they structure their training organizations to deliver lasting impact.Views expressed are those of the speakers and do not constitute product endorsements.This episode is sponsored by uPerform.

In this episode of our progesterone series (Episode 5), Dr. Brendan McCarthy — Chief Medical Officer of Protea Medical Center in Tempe, Arizona — breaks down the often-misunderstood relationship between stress, ovulation, progesterone, and cortisol. We explore the concept commonly referred to as the “progesterone steal” and why this term can be misleading. Rather than hormones being “stolen,” Dr. McCarthy explains how the body intelligently reroutes hormone production under stress to prioritize survival over reproduction. This episode covers: Why the body must feel safe to ovulate and produce progesterone How chronic stress impacts PMS, fertility, and cycle regularity The truth about cortisol (and why it isn't the villain it's often made out to be) Why low progesterone is not a personal failure or flaw Why you can't medicate someone out of stress — and what good medicine actually looks like This conversation is about biology, not blame. Your body is not broken — it's responding exactly as designed. Dr. Brendan McCarthy is the founder and Chief Medical Officer of Protea Medical Center in Arizona. With over two decades of experience, he's helped thousands of patients navigate hormonal imbalances using bioidentical HRT, nutrition, and root-cause medicine. He's also taught and mentored other physicians on integrative approaches to hormone therapy, weight loss, fertility, and more. If you're ready to take your health seriously, this podcast is a great place to start.  

GLP-1s have quickly become a cornerstone of obesity and metabolic care — but the real challenge isn't whether they work, it's how the healthcare system uses them. Leaders are grappling with tough questions around hype, access, safety, cost, and long-term sustainability. In this episode, recorded live at the 2025 HLTH conference, Rae Woods moderates a candid conversation with four physician leaders: Angela Fitch, MD: Co-founder and Chief Medical Officer at Knownwell Florencia Halperin, MD: Chief Medical Officer at Form Health Spencer Nadolsky, MD: CEO and Founder of Vineyard Nathan Wood, MD: Director of Culinary Medicine at Yale Drawing from frontline clinical experience and emerging data, the panel explores why medication only approaches fall short, how wraparound care improves outcomes and adherence, and what it will take for GLP 1s to deliver true value for patients, employers, and payers. We're here to help: Ep. 229: Live from HLTH: What Can't GLP-1s Do? Ep. 248: Drugs, surgeries, and shortages: the state of obesity care in 2025 Ep. 222: It's not just GLP-1s; here's what comprehensive weight management looks like Ep. 279: ‘Food as medicine': What it is, why it matters, and how to do it right 5 trends shaping pharma strategy for 2026 (and how to adapt) Innovative solutions to today's obesity care challenges From reactive to proactive care: 4 key takeaways about today's COVID-19 landscape A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.